Clinical Trial Update: Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nimotuzumab in combination with chemotherapy for persistent or recurrent stage IVB cervical squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Cervical Squamous Cell Carcinoma, Persistent | Phase 3 | Status: COMPLETED